Release 4B

This page is part of the FHIR Specification (v4.3.0: R4B - STU). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B

Biomedical Research and Regulation Work GroupMaturity Level: N/AStandards Status: InformativeSecurity Category: Anonymous Compartments: Not linked to any defined compartments

Mappings:

Mappings for the regulatedauthorization resource (see Mappings to Other Standards for further information & status).

RegulatedAuthorizationMarketing Authorisation, Clinical Trial Authorisation
    identifierMarketing Authorisation.Marketing Authorisation Number
    subject(the link to Medicinal Product or Packaged Medicinal Product)
    typen/a
    descriptionn/a
    regionMarketing Authorisation.Country
    statusMarketing Authorisation.Authorisation Status
    statusDateMarketing Authorisation.Authorisation Status Date
    validityPeriodMarketing Authorisation.Validity Period Start, Marketing Authorisation.Validity Period End
    indicationn/a
    intendedUsen/a
    basisMarketing Authorisation.Status Reasons.Legal Grounds
    holderMarketing Authorisation.Marketing Authorisation Holder (Organisation)
    regulatorMarketing Authorisation.Medicines Regulatory Agency (Organisation)
    caseMarketing Authorisation.Marketing Authorisation Procedure, Marketing Authorisation Procedure.Marketing Authorisation Application
        identifierMarketing Authorisation Procedure.Procedure Identifier / Number, Marketing Authorisation Application.Application Identifier / Number
        typeMarketing Authorisation Procedure.Procedure Type, Marketing Authorisation Application.Application Type
        statusn/a
        date[x]Marketing Authorisation Procedure.Procedure Date Start, Marketing Authorisation Procedure.Procedure Date End, Marketing Authorisation Application.Application Date
        applicationMarketing Authorisation.Marketing Authorisation Application